EU funding updates
Information on the Horizon Europe and the EU4Health research programmes, including new funding calls, opening dates and upcoming deadlines.
7 min read - 30 Jul 2025

Information on the Horizon Europe and the EU4Health research programmes, including new funding calls, opening dates and upcoming deadlines.
Open Calls
Horizon Europe Health Cluster 2025
The Horizon Europe Health Cluster 2025 Work Programme has been published and you can find it here.
Single stage calls opened on 22 May and will close on 16 September 2025. They include:
Destination 3
- HORIZON-HLTH-2025-01-DISEASE-01: Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections
- HORIZON-HLTH-2025-01-DISEASE-03: Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential
- HORIZON-HLTH-2025-01-DISEASE-04: Leveraging artificial intelligence for pandemic preparedness and response
- HORIZON-HLTH-2025-01-DISEASE-05: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
- HORIZON-HLTH-2025-01-DISEASE-06: Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD)
- HORIZON-HLTH-2025-01-DISEASE-07: Tackling high-burden for patients and under-researched medical conditions
Destination 4
- HORIZON-HLTH-2025-01-CARE-01: End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU)
Destination 5
- HORIZON-HLTH-2025-01-TOOL-01: Enhancing cell therapies with genomic techniques
- HORIZON-HLTH-2025-01-TOOL-02: Advancing cell secretome-based therapies
- HORIZON-HLTH-2025-01-TOOL-03: Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU)
- HORIZON-HLTH-2025-01-TOOL-05: Boosting the translation of biotech research into innovative health therapies
Destination 6
- HORIZON-HLTH-2025-01-IND-01: Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs)
- HORIZON-HLTH-2025-01-IND-02: Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices
Two-stage calls opened on 22 May. First stage deadline is on 16 September 2025. Successful proposals will go through to the 2nd stage with a deadline of 16 April 2026.
Destination 1
- HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage: Improving the quality of life of persons with intellectual disabilities and their families
Destination 2
- HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage: The impact of pollution on the development and progression of brain diseases and disorders
- HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage: Advancing knowledge on the impacts of micro- and nanoplastics on human health
Destination 3
- HORIZON-HLTH-2025-03-DISEASE-02-two-stage: Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders
Destination 6
- HORIZON-HLTH-2025-03-IND-03-two-stage: Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices
2025 Health Cluster Info Day recordings are available here. Please, find in this HNN3.0 document, all the questions asked during the session with the link to the exact minute in the video where each question was answered.
Cancer Mission 2025
The Cancer Mission 2025 Work Programme has been published and you can find it here. Deadline for the Cancer Mission calls is 16 September 2025.
Calls include:
- HORIZON-MISS-2025-CANCER-02-01: Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research
- HORIZON-MISS-2025-CANCER-02-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
- HORIZON-MISS-2025-CANCER-02-03: Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefitting cancer patients with locally advanced or metastatic disease
- HORIZON-MISS-2025-CANCER-02-04: Investigator-initiated multinational early-stage innovative clinical trials for paediatric cancer
- HORIZON-MISS-2025-CANCER-02-05: Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition
- HORIZON-MISS-2025-CANCER-02-06: Support to the network of National Cancer Mission Hubs (NCMHs)
A joint call between the Cancer Mission and the Climate-Neutral and Smart Cities Mission is also open. Deadline for proposal submission is 4th September 2025.
- HORIZON-MISS-2025-06-CIT-CANCER-01: Increasing walking and cycling: to reap health benefits, emission reductions and integrate active mobility and micro-mobility devices, with smart technologies and infrastructure
Cancer Mission 2025 Info Day recording is available here.
For more information on Horizon Europe Health Cluster or the Cancer Mission, please contact the Health NCP at icastellano@hrb.ie
ERDERA Networking Support Scheme
The Networking Support Scheme (NSS) is a continuously open call designed to knit together researchers, clinicians and patient advocates working on rare diseases and rare cancers. Proposals may be lodged at any time, but the first collection round will be assessed immediately after the 7 October 2025 deadline, allowing successful teams to start planning events without delay.
Under the scheme, applicants can request up to €30,000 per networking event to cover meeting costs, travel costs, hybrid-meeting platforms and other essentials. Rounds will be held every six months until April 2029 – or until the dedicated budget is exhausted -providing a response pathway for emerging collaborations of the partnership.
What is the aim?
- To promote the exchange of scientific knowledge.
- To empower underrepresented countries to join and contribute to rare disease and rare cancer research.
Who is it for?
- Clinicians, researchers, patient advocacy organisations and research managers working in or building new or expanding research networks.
Applications will be open on a continuous basis – collected every 6 months, starting 7 October 2025. Each event must gather applicants from at least three ERDERA countries and focus squarely on knowledge exchange in rare disease or rare cancer research. Meetings may run in person or in hybrid formats to maximise reach.
More information, such as guidance notes, evaluation criteria and the full list of eligible countries are available on the ERDERA website.
European Partnership for Personalised Medicine (EP PerMed) Education Call
The Education Call will provide funding (up to €50,000) to support the provision and development of educational content aimed at healthcare professionals (HCPs) in the implementation of personalised medicine (PM).
The gaps in the PM knowledge and skills among HCPs have been identified as one key barrier to the implementation of PM. This initiative will enhance the capacity of HCPs to integrate PM into their daily practice, ensuring they are equipped with the necessary knowledge, skills, and competencies.
The scope includes general and specialised education on PM and its implementation in clinical practice, interdisciplinary collaboration between HCPs, as well as effective communication of HCPs with patients. The courses will be designed and implemented collaboratively between selected consortia and EP PerMed.
The call aims to fund high quality content that will feed into online modules/ courses, that will be collaboratively developed with the Digital Learning Team supporting EP PerMed. All modules/ courses will be hosted and disseminated through the EP PerMed website and the eLearning platform designated by EP PerMed.
Application Deadline is 9 September 2025 and for further information see Education Call: Guide to Personalised Medicine for Healthcare Professionals – European Partnership for Personalised Medicine – EP PerMed
Innovative Health Initiative
Innovative Health Initiative – call 11
IHI call 11 is open and it is a two-stage call. Short proposal submission deadline is 9 October 2025 at 16:00 IST and full proposal submission deadline is 29 April 2026 at 16:00 (IST). Topics included in this call are:
- Topic 1: Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction
- Topic 2: Understanding how infections foster and induce non-communicable diseases
- Topic 3: AI-powered signal detection in pharmacovigilance
- Topic 4: Leveraging Europe’s expertise to accelerate cell therapy for type 1 diabetes
- Topic 5: Establishing ortho and cardiology ambulatory surgical centres in Europe
IHI will hold a brokerage event in Brussels, Belgium on 4 – 5 November 2025 to provide people interested in IHI’s next single-stage call with the opportunity to network face-to-face and start forming consortia. Find more information here.
European Innovation Council (EIC)
EIC Pathfinder Challenges 2025
The EIC Pathfinder supports the earliest phases of scientific and technical research and development of future, groundbreaking, market-creating technologies. These visionary and high-risk projects are supported at an early stage (TRL 1-4) of development. Budget per project between €3 – 4 million.
The EIC Pathfinder Challenges is for projects that match any of the predefined thematic areas of the programme. There is one Challenge relevant for health researchers currently open. Closing deadline for proposals is 29 October 2025.
- HORIZON-EIC-2025-PATHFINDERCHALLENGES-01-02: Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer
Upcoming calls
EU4Health
The EU4Health 2025 Work Programme was published on 23 July 2025 and is available here
The first calls for proposals are expected to launch in September 2025. The tentative call calendar is published on HaDEA’s webpage and will be updated with more specific timelines in due course.
See also the HRB website for general information on the Horizon Europe and EU4Health programmes.
7 min read - 30 Jul 2025